Table I.
Patient Demographics
| Patient | Gender | Disease | Age at SCT | Donor | Age at last F/U | Years to F/U | Prior CNS Therapy |
|---|---|---|---|---|---|---|---|
| 1 | M | AML | 2.0 | UCB | 11.3 | 9.3 | IT/CB |
| 2 | M | AML | 0.4 | UCB | 3.5 | 3.1 | IT |
| 3 | F | ALL | 2.3 | MS | 13.1 | 10.8 | None |
| 4 | F | ALL | 2.5 | MS | 9.8 | 7.3 | IT/CB |
| 5a | F | Large Cell Lymphoma |
0.9 | 1.UCB 2.MUD |
4.7 | 3.8 | None |
| 6 | F | AML | 1.9 | UCB | 10.5 | 8.6 | IT |
| 7 | M | AML | 1.5 | MS | 2.9 | 1.4 | IT |
| 8 | F | ALL | 1.6 | UCB | 13.9 | 12.3 | IT |
| 9 | F | ALL | 0.5 | No record | 13.5 | 13.0 | IT |
| 10 | F | ALL | 1.8 | UCB | 3.6 | 1.8 | IT/CB |
| 11 | F | ALL | 0.7 | UCB | 9.4 | 8.7 | IT |
| 12 | F | ALL | 1.5 | UCB | 11.6 | 10.1 | None |
| 13 | M | ALL | 0.7 | UCB | 10.1 | 9.4 | CB |
| 14 | M | ALL | 0.6 | UCB | 8.3 | 7.7 | None |
| 15 | F | ALL | 2.8 | MS | 6.1 | 3.3 | IT |
UCB, unrelated cord blood; MS, matched sibling; IT, intrathecal chemotherapy; CB, cranial boost radiation.
a
indicates patient underwent two SCTs.